*Assisted step by step workflow with automated checks, hard-stops and documentation.
** * BD Cato™ Prescribe (version 2.49 and higher) is a medical device and fulfils the requirements for CE marking of the Regulation (EU) 2017/745 and is marked with
References
1. Weingart SN, Zhang L, Sweeney M, Hassett M. Chemotherapy medication errors. Lancet Oncol. 2018;19(4): e191-e199. https://pubmed.ncbi.nlm.nih.gov/29611527/
2. Sutherland A, Ashcroft DM, Phipps DL. Exploring the human factors of prescribing errors in paediatric intensive care units. Archives of Disease in Childhood 2019;104:588-595. https://adc.bmj.com/content/104/6/588
3. Terkola R, Czejka M, Berube J. Evaluation of real-time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic
impact: Results of a large-scale, multicentre, multinational, retrospective study. J Clin Pharm Ther. 2017;42(4):446-453. https://pubmed.ncbi.nlm.nih.gov/28429389/
4. Strub et al. Poster at Internationaler Kongress November 2011
5. East Tallin Nurse Satisfaction Survey. 2019.
6. Waterson J, Meren ÜH. Automated and Closed Loop Oncology Agent Compounding and Administration; Gains in Safety and Efficiency. JMIR Hum Factors. 2021 Aug 25. doi:
10.2196/29180. Epub ahead of print. PMID: 34456182.
2021 BD. BD, the BD Logo, Cato and all other trademarks are property of Becton, Dickinson and Company. All trademarks are property of their respective owners. BD-45272 Issue 1
